A Double-blind, Placebo-controlled, Parallel-group, Flexible-dose Study of Venlafaxine Extended-release Capsules in Adult Outpatients With Panic Disorder.

Trial Profile

A Double-blind, Placebo-controlled, Parallel-group, Flexible-dose Study of Venlafaxine Extended-release Capsules in Adult Outpatients With Panic Disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Oct 2009

At a glance

  • Drugs Venlafaxine (Primary)
  • Indications Panic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Aug 2009 Actual end date (Dec 2002) added as reported by ClinicalTrials.gov
    • 18 Aug 2009 Actual initiation date (Apr 2001) added as reported by ClinicalTrials.gov.
    • 18 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top